X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-21 | BLK | Kushel J. Richard | Senior MD | S - Sale+OE | $1,010.00 | -10,000 | 145,736 | -6% | -$10,100,000 | |||||
| D | 2024-12-06 | BLK | Wiedman Mark | Senior MD | S - Sale+OE | $1,045.90 | -36,190 | 6,480 | -85% | -$37,851,104 | |||||
| D | 2024-12-06 | BLK | Meade Christopher J. | GC, CLO | S - Sale+OE | $1,045.83 | -18,000 | 8,436 | -68% | -$18,824,988 | |||||
| D | 2024-12-05 | BLK | Goldstein Robert L. | COO | S - Sale+OE | $1,046.03 | -54,000 | 50,401 | -52% | -$56,485,636 | |||||
2024-12-04 | BLK | Fink Laurence | COB, CEO | S - Sale | $1,035.76 | -48,700 | 295,090 | -14% | -$50,441,711 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |